Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
National Comprehensive Cancer Network Joins Collaboration to Improve Standards in Cancer Care for Vietnam 2023-06-01 09:00
Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy 2023-06-01 09:00
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders 2023-06-01 08:00
Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency 2023-06-01 04:24
Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument 2023-06-01 00:57
Advances of Qilu Pharmaceutical's QL1706 in Clinical Research Presented at ASCO Annual Meeting 2023-06-01 00:55
Vazyme Signs Global Strategic Cooperation Agreement with Azenta 2023-05-31 22:24
Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention 2023-05-31 20:58
Caliway Biopharmaceuticals Announces Initiation of Subject Recruitment in CBL-0204 Phase 2b Study Evaluating the Efficacy of CBL-514 in Abdominal Subcutaneous Fat Reduction 2023-05-31 20:15
QBIOTICS TO PRESENT AT SACHS 9TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM AND THE BIO INTERNATIONAL CONVENTION 2023-05-31 19:00
Asieris' progress in MIBC receives renewed attention with its inclusion in ASCO 2023 2023-05-31 16:00
THINK Surgical's TMINI Miniature Robotic System developed with Sagentia Innovation gains FDA 510(k) clearance 2023-05-31 15:00
SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy 2023-05-31 14:58
Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement 2023-05-31 14:30
【 C.S 】: The first company with Cordyceps sinensis assets as the main body was successfully listed on the US SEC 2023-05-31 13:12
Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC 2023-05-31 13:02
AffaMed Therapeutics Announces Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Cataract Surgery Patients 2023-05-31 11:39
Waterdrop Inc. Announces Earnings Date Change: First Quarter 2023 Earnings Release Scheduled June 2, 2023 2023-05-31 11:19
Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug 2023-05-31 10:20
Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Financing to Accelerate Clinical Development of Core Products 2023-05-31 08:25
1 148 149 150 151 152 1502